
E-cigarettes could be prescribed on the NHS in world first
Peer reviewed by Dr Sarah JarvisAuthored by Emily Jane BashforthOriginally published 20 Nov 2021
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
As part of the government's ambition to make England smoke-free by 2030, we could become the first country in the world to prescribe medicinally licensed e-cigarettes.
Get support to stop smoking
Get expert healthcare advice from the comfort of home. Complete a quick online consultation, available 24/7, with your request reviewed by a UK-registered clinician. Next day delivery available on eligible treatments.
Video picks for Smoking and vapingVideo library
With the government wanting to reduce smoking rates, prescribing e-cigarettes could be a way of helping people stop smoking tobacco products.
What do those in charge think?
The idea is still in its early stages and medical regulators will collaborate with manufacturers to ensure the products are safe and effective. However, Health and Social Care Secretary Sajid Javid welcomes the step forward in the licensing process for manufacturers.
"This country continues to be a global leader on healthcare, whether it's our COVID-19 vaccine rollout saving lives or our innovative public health measures reducing people's risk of serious illness.
"Opening the door to a licensed e-cigarette prescribed on the NHS has the potential to tackle the stark disparities in smoking rates across the country, helping people stop smoking wherever they live and whatever their background," he said.
How will it work?
The Medicines and Healthcare products Regulatory Agency (MHRA) is now allowing manufacturers to submit their e-cigarette products for approval. The regulatory approvals for e-cigarettes are the same as for other medicines available on the health service.
Those given the green light could become licensed medical products. However, it will be down to clinicians to decide on a case-by-case basis whether prescribing an e-cigarette would help a tobacco smoker quit.
It remains the case that non-smokers and children are strongly advised against using e-cigarettes.
Will prescribing e-cigarettes actually reduce smoking rates?
Most e-cigarettes contain nicotine and they are not risk free. However, expert reviews from the UK and USA have been clear that the regulated e-cigarettes are less harmful than smoking. A medicinally licensed e-cigarette would have to pass even more rigorous safety checks.
Smoking remains the leading preventable cause of premature death. While rates are at record low levels in the UK, there are still around 6.1 million smokers in England.
E-cigarettes were the most popular aid used by smokers trying to quit in England in 2020. They have been shown to be highly effective in supporting those trying to quit, with 27.2% of smokers using them. In comparison, 18.2% use nicotine replacement therapy products, such as patches and gum.
Some of the highest success rates of those trying to quit smoking are among people using an e-cigarette to kick their addiction. Up to 68% of smokers successfully quit in 2020-2021 if they combined e-cigarettes with expert input from local Stop Smoking services.
Almost 64,000 people died from smoking in England in 2019 and the Office for Health Improvement and Disparities (OHID) is supporting efforts to level up public health and ensure communities across the country have equal health outcomes.
The e-cigarette initiative also hopes to tackle the stark differences in smoking rates across the country. Smoking rates in Blackpool (23.4%) and Kingston upon Hull (22.2%) are poles apart from rates in wealthier areas, such as Richmond upon Thames (8%).
Reducing health disparities - including in smoking rates - and keeping people in better health for longer are good for the individual, families, society, the economy and the NHS. To achieve this overall ambition, the OHID will work collaboratively at national, regional and local levels. They will also work alongside the NHS, academia, the third sector, scientists, researchers and industry.
The government will soon publish a new Tobacco Control Plan which will set out the roadmap for achieving a smoke-free England by 2030.
Patient picks for Smoking and vaping

General health and lifestyle
The Patient Charter: Your rights, NHS pledges and responsibilities
The NHS is one of the UK’s proudest achievements. It was founded on the principle that healthcare should be available to everyone, free at the point of use, and based on need rather than ability to pay. To make sure that principle is protected, the NHS Constitution sets out what patients, the public, and staff can expect. Sometimes called the Patient Charter, it pulls together your legal rights (which the NHS must uphold), alongside the pledges the NHS makes to you (commitments that go beyond what the law requires). It also includes your responsibilities as a patient because the NHS can only function if we all use it fairly and respectfully. But what does this mean in practice? And why does it matter in real life, especially at a time when the NHS is under huge strain? Let’s explore.
by Thomas Andrew Porteus, MBCS

General health and lifestyle
Why is medical cannabis so hard to access on the NHS?
Medical cannabis has been legal to prescribe in the UK for almost eight years, so why have only a handful of people been able to access it on the NHS?
by The Medical Cannabis Clinicians Society

General health and lifestyle
Book a Pharmacy First online consultation
NHS Pharmacy First is a new scheme from the Government and NHS in England. It allows patients to get treatment, including prescription medications where necessary, for common conditions without the need for a GP appointment. Through NHS Pharmacy First, My Local Surgery offers fast, free private online consultations with an NHS pharmacist for quick.
by Thomas Andrew Porteus, MBCS

Sexual health
Should HIV prevention pills be available on the NHS?
I don't know if you've noticed, but the NHS costs a lot. In 2015/2016, the NHS spent £14.4 billion on drugs alone, a rise of 8% on the previous year and 29% higher than 2010/2011. Of course, there are cost 'efficiencies' which need to be made, but sometimes we have to weigh up the long-term savings against the short-term costs.
by Dr Sarah Jarvis

Tests and investigations
NHS to roll out world-first blood test for cancer
People with lung and breast cancer – two of the most common forms of cancer - will be offered a ‘revolutionary’ new blood test, which will help speed up and personalise their treatment.
by Lawrence Higgins

General health and lifestyle
Neighbourhood health: What the NHS changes could mean for your care
For years, one of the most common frustrations patients have shared is how fragmented healthcare can feel. You tell your story to one professional, then repeat it again somewhere else. You travel for appointments that feel like they could have happened closer to home. Too often, care only steps in once something has already gone wrong. The latest plans from NHS England are an attempt to change that pattern. They do not introduce a single new service or a quick fix. Instead, they outline a different way of organising care, one that is more local, more connected, and more focused on keeping you well.
by Thomas Andrew Porteus, MBCS
About the reviewerView full bio

Dr Sarah Jarvis
Clinical Consultant
MA (Cantab), BM, BCh (Oxon), DRCOG, FRCGP, MBE
After training in medicine at Cambridge and Oxford, Dr Sarah Jarvis MBE became a GP.
Article history
Article also available in English, German, Spanish, French, Italian, Portuguese, Hindi, Hebrew, Arabic, and Swedish.
20 Nov 2021 | Originally published
Authored by:
Emily Jane BashforthPeer reviewed by
Dr Sarah Jarvis
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.
